Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives

Details for Australian Patent Application No. 2006258300 (hide)

Owner AstraZeneca AB

Inventors Nilsson, Ingemar; Polla, Magnus

Agent Davies Collison Cave

Pub. Number AU-A-2006258300

PCT Pub. Number WO2006/135323

Priority 0501413-9 17.06.05 SE

Filing date 14 June 2006

Wipo publication date 21 December 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 213/73 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135323 Priority application(s): WO2006/135323

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258301-Soft magnetic composite materials

2006258293-New oxabispidine compounds for the treatment of cardiac arrhythmias